Shandong Sito Bio-technology Co Ltd - Asset Resilience Ratio

Latest as of September 2020: 0.35%

Shandong Sito Bio-technology Co Ltd (300583) has an Asset Resilience Ratio of 0.35% as of September 2020. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 300583 net working capital ratio to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

CN¥10.00 Million

≈ $1.46 Million USD Cash + Short-term Investments

Total Assets

CN¥2.87 Billion

≈ $419.27 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2017–2019)

This chart shows how Shandong Sito Bio-technology Co Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Shandong Sito Bio-technology Co Ltd assets under control.

Liquid Assets Composition Over Time

This chart breaks down Shandong Sito Bio-technology Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore Shandong Sito Bio-technology Co Ltd (300583) long-term investment share to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥10.00 Million	0.35%
Total Liquid Assets	CN¥10.00 Million	0.35%

Asset Resilience Insights

Limited Liquidity: Shandong Sito Bio-technology Co Ltd maintains only 0.35% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Shandong Sito Bio-technology Co Ltd Industry Peers by Asset Resilience Ratio

Compare Shandong Sito Bio-technology Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Ligand Pharmaceuticals Incorporated NASDAQ:LGND	Biotechnology	16.06%
Halozyme Therapeutics Inc NASDAQ:HALO	Biotechnology	12.71%
Revolution Medicines Inc NASDAQ:RVMD	Biotechnology	72.23%
Abivax SA PA:ABVX	Biotechnology	2.34%
Shanghai Allist Pharmaceuticals Co. Ltd. A SHG:688578	Biotechnology	21.11%
Beijing Tiantan Biological Products Corp Ltd SHG:600161	Biotechnology	8.08%
SOLENO THERAPEUT. DL-001 F:6XC	Biotechnology	41.74%
Tibet Cheezheng Tibetan Medicine Co Ltd SHE:002287	Biotechnology	37.31%

Annual Asset Resilience Ratio for Shandong Sito Bio-technology Co Ltd (2017–2019)

The table below shows the annual Asset Resilience Ratio data for Shandong Sito Bio-technology Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2019-12-31	6.81%	CN¥203.36 Million ≈ $29.76 Million	CN¥2.99 Billion ≈ $437.13 Million	-14.84pp
2018-12-31	21.64%	CN¥561.57 Million ≈ $82.18 Million	CN¥2.59 Billion ≈ $379.65 Million	-5.96pp
2017-12-31	27.61%	CN¥558.88 Million ≈ $81.78 Million	CN¥2.02 Billion ≈ $296.26 Million	--

pp = percentage points

About Shandong Sito Bio-technology Co Ltd

SHE:300583 China Biotechnology

Market Cap

$371.14 Million

CN¥2.54 Billion CNY

Market Cap Rank

#13962 Global

#4207 in China

Share Price

CN¥13.37

Change (1 day)

-1.26%

52-Week Range

CN¥10.95 - CN¥16.25

All Time High

CN¥50.68